<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gao SY</submitter><funding>Clinical Youth Cadre Hospital Fund of Shanghai Children's Medical Center</funding><funding>2024-National Clinical Key Specialty Construction Project</funding><funding>Special Fund for People's Livelihood Scientific Research of Public Institutions under the Science and Technology Development Fund of Pudong New Area</funding><funding>National Nature Science Foundation of China</funding><funding>Special Fund for People&amp;apos;s Livelihood Scientific Research of Public Institutions under the Science and Technology Development Fund of Pudong New Area</funding><funding>Clinical Youth Cadre Hospital Fund of Shanghai Children&amp;apos;s Medical Center</funding><pagination>247-257</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12923387</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Type 1 diabetes mellitus is a heterogeneous autoimmune disease with diverse characteristics between ethnicities and ages. Understanding this heterogeneity is essential for optimizing management and developing precision treatments. This study investigates the clinical, metabolic and immunological heterogeneity of type 1 diabetes mellitus in children across different ages of onset.&lt;h4>Methods&lt;/h4>A retrospective analysis of 401 children newly diagnosed with type 1 diabetes mellitus at a single center from January 2009 to August 2024 was conducted. We compared the clinical characteristics of our cohort with others from different countries. Patients were categorized into three age groups: 6 months-5 years, 5-10 years and ≥ 10 years at diagnosis. Clinical, metabolic, and immu</pubmed_abstract><journal>World journal of pediatrics : WJP</journal><pubmed_title>Age-related heterogeneity of type 1 diabetes mellitus in children: a single-center retrospective study.</pubmed_title><pmcid>PMC12923387</pmcid><funding_grant_id>PKJ2025-Y03</funding_grant_id><funding_grant_id>QN-SCMC2023-5</funding_grant_id><funding_grant_id>No.10000015Z155080000004</funding_grant_id><funding_grant_id>82170910</funding_grant_id><pubmed_authors>Gao SY</pubmed_authors><pubmed_authors>Huang YG</pubmed_authors><pubmed_authors>Wang LB</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Wang XM</pubmed_authors><pubmed_authors>Chang GY</pubmed_authors><pubmed_authors>Hu FH</pubmed_authors><pubmed_authors>Zhang QW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age-related heterogeneity of type 1 diabetes mellitus in children: a single-center retrospective study.</name><description>&lt;h4>Background&lt;/h4>Type 1 diabetes mellitus is a heterogeneous autoimmune disease with diverse characteristics between ethnicities and ages. Understanding this heterogeneity is essential for optimizing management and developing precision treatments. This study investigates the clinical, metabolic and immunological heterogeneity of type 1 diabetes mellitus in children across different ages of onset.&lt;h4>Methods&lt;/h4>A retrospective analysis of 401 children newly diagnosed with type 1 diabetes mellitus at a single center from January 2009 to August 2024 was conducted. We compared the clinical characteristics of our cohort with others from different countries. Patients were categorized into three age groups: 6 months-5 years, 5-10 years and ≥ 10 years at diagnosis. Clinical, metabolic, and immu</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T14:47:37.969Z</modification><creation>2026-07-09T11:02:07.332Z</creation></dates><accession>S-EPMC12923387</accession><cross_references><pubmed>41455069</pubmed><doi>10.1007/s12519-025-01004-3</doi></cross_references></HashMap>